Company news

Alexandria Real Estate Equities, Inc. (NYSE:ARE) news

Alexandria Real Estate Equities, Inc. news releases on 6ix. Latest, Sep 28, 2026: Alexandria Real Estate Equities, Inc. Announces Closing of Amended…

Alexandria Real Estate Equities, Inc. (NYSE:ARE) news

Press releases & updates

Alexandria Real Estate Equities, Inc. Announces Closing of Amended and Restated $5.0 Billion Unsecured Senior Line of Credit

Alexandria Real Estate Equities, Inc. Highlights Its Role in Advancing Blood Cancer Innovation by Enabling Life-Changing Tenant R&D, Mission-Critical Philanthropic Initiatives and Strategic Investments

Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $0.72 per Common Share for 3Q26

Alexandria Real Estate Equities, Inc. to Hold Its Third Quarter 2026 Operating and Financial Results Conference Call and Webcast on October 27, 2026

Alexandria Real Estate Equities, Inc. Announces Pricing of Public Offering of $1,000,000,000 of Series A Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2057

Alexandria Real Estate Equities, Inc. Reports 2Q26 and 1H26 Net (Loss) Income per Share - Diluted of $(0.43) and $1.68, respectively, and 2Q26 and 1H26 FFO per Share - Diluted, as Adjusted, of $1.73 and $3.46, respectively

Alexandria Real Estate Equities, Inc. Announces Foundational Milestone in Mission-Critical Partnership with the Foundation for the National Institutes of Health to Advance Precision Medicine for Depression

Alexandria Real Estate Equities, Inc. Delivers 427,000 RSF Innovative Research & Development Hub for a Multinational Pharmaceutical Company at the Campus Point by Alexandria Megacampus™ in San Diego

Alexandria Real Estate Equities, Inc. Releases 2025 Corporate Responsibility Report Highlighting Strategic Integration of Mission, Innovation and Long-Term Value Creation

Alexandria Real Estate Equities, Inc. Recognized Among Top 20 Companies for Talent Readiness in The Wall Street Journal's "Best Companies for the Future"

Alexandria Real Estate Equities, Inc. Continues its Generational Consequential Leadership as Pioneer of The Commercial Life Science Ecosystem and Second Most Active Early-Stage Life Science Investor in its New York City Life Science Cluster

Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $0.72 per Common Share for 2Q26

Alexandria Real Estate Equities, Inc. to Hold Its Second Quarter 2026 Operating and Financial Results Conference Call and Webcast on August 4, 2026

Alexandria Real Estate Equities, Inc. Celebrates Consequential Impact Achieved Through its Longstanding Partnership with the Navy SEAL Foundation

Joel S. Marcus, Executive Chairman and Founder of Alexandria Real Estate Equities, Inc., Honored with the Prestigious Richard J. Bolte Sr. Award from the Science History Institute Museum & Library in Recognition of His Consequential Long-Term Impact on the Life Science Industry

Alexandria Real Estate Equities, Inc. Reports 1Q26 Net Income per Share - Diluted of $2.10; and 1Q26 FFO per Share - Diluted, as Adjusted, of $1.73

Alexandria Real Estate Equities, Inc. Named One of the Most Trustworthy Companies in America by Newsweek for Fourth Consecutive Year

Aecon Announces Closing of Offering of Common Shares

Aecon schedules first quarter 2026 financial results release and conference call

Aecon joint venture finalizes contract for the Howard A. Hanson Dam Facility project in Washington State

Aecon Announces Filing of Final Short Form Prospectus in Connection with Offering of Common Shares

Alexandria Real Estate Equities, Inc. Named One of the Most Charitable Companies in America by Newsweek

Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $0.72 per Common Share for 1Q26

Alexandria Real Estate Equities, Inc. to Hold Its First Quarter 2026 Operating and Financial Results Conference Call and Webcast on April 28, 2026

Alexandria Real Estate Equities, Inc. Announces Pricing of Public Offering of $750,000,000 of Senior Notes due 2036

Alexandria Real Estate Equities, Inc. Announces Pricing Terms of Cash Tender Offers

Alexandria Real Estate Equities, Inc. Announces Public Offering of Senior Notes

Alexandria Real Estate Equities, Inc. Announces Early Results and Upsizing of Cash Tender Offers

Alexandria Real Estate Equities, Inc. Announces Cash Tender Offers

Alexandria Real Estate Equities, Inc. Reports 4Q25 and 2025 Net Loss per Share - Diluted of $6.35 and $8.44, respectively; and 4Q25 and 2025 FFO per Share - Diluted, as Adjusted, of $2.16 and $9.01, respectively

Alexandria Real Estate Equities, Inc. Announces Tax Treatment of Year 2025 Distributions

Alexandria Real Estate Equities, Inc. Celebrates 32 Years of Pioneering Leadership in Life Science Real Estate and Consequential Impact on Advancing Human Health

Alexandria Real Estate Equities, Inc. to Hold Its Fourth Quarter and Year End 2025 Operating and Financial Results Conference Call and Webcast on January 27, 2026

Alexandria Real Estate Equities, Inc. Refreshes and Extends Its $500 Million Common Stock Repurchase Program

Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $0.72 per Common Share for 4Q25, a Decrease of $0.60, or 45%, Compared to 3Q25

Alexandria Real Estate Equities, Inc. Reports: 3Q25 and YTD 3Q25 Net Loss per Share - Diluted of $(1.38) and $(2.09), respectively; and 3Q25 and YTD 3Q25 FFO per Share - Diluted, as Adjusted, of $2.22 and $6.85, respectively

Alexandria Real Estate Equities, Inc./Alexandria Venture Investments Receives 2025 Charles A. Sanders, MD, Partnership Award From the Foundation for the National Institutes of Health

Alexandria Real Estate Equities, Inc. Strategically Partners With Lilly on Newest Lilly Gateway Labs at the One Alexandria Square Megacampus in San Diego's Torrey Pines to Accelerate the Development of Life-Changing Medicines

Alexandria Real Estate Equities, Inc. Named One of the World's Most Trustworthy Companies by Newsweek for the Second Consecutive Year

Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.32 per Common Share for 3Q25

Alexandria Real Estate Equities, Inc. to Hold Its Third Quarter 2025 Operating and Financial Results Conference Call and Webcast on October 28, 2025

Cohen & Steers Announces Changes to Realty Indexes

Alexandria Real Estate Equities, Inc. Reports: 2Q25 and 1H25 Net Loss per Share - Diluted of $(0.64) and $(0.71), respectively; and 2Q25 and 1H25 FFO per Share - Diluted, as Adjusted, of $2.33 and $4.63, respectively

Alexandria Real Estate Equities, Inc. Wins Its First International TOBY (The Outstanding Building of the Year) Award in Life Science Category for 8 Davis Drive Anchoring the Alexandria Center for Advanced Technologies Megacampus in Research Triangle

Alexandria Real Estate Equities, Inc. Executes Largest Life Science Lease in Company History With Longtime Multinational Pharmaceutical Tenant for a 466,598 RSF Build-to-Suit Research Hub at the Campus Point Megacampus in San Diego

Alexandria Real Estate Equities, Inc. Releases 2024 Corporate Responsibility Report Highlighting Its Strategic Initiatives That Catalyze Positive Change for the Benefit of Human Health and Advance Its Sustainability Impact

RyboDyn Selected to Join Lilly Gateway Labs to Advance Next-Gen Immunotherapies Targeting the Dark Proteome

Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.32 per Common Share for 2Q25

Alexandria Real Estate Equities, Inc. to Hold Its Second Quarter 2025 Operating and Financial Results Conference Call and Webcast on July 22, 2025

Alexandria Real Estate Equities, Inc. Enhances Its Corporate Responsibility Pillar Focused on Driving Educational Opportunities With Opening of New Learning Lab at Fred Hutch Dedicated to Inspiring and Training Future Scientists